Skip to main content

Table 8 In vivo anti-inflammatory activity: carrageenan-induced hind paw edema

From: Topical gel based nanoparticles for the controlled release of oleanolic acid: design and in vivo characterization of a cubic liquid crystalline anti-inflammatory drug

Treatment

Anti-inflammatory activity

Time

0

1

2

4

8

12

24

Control

Edema rate

0.00 ± 0.02

34.12 ± 0.02

43.87 ± 0.02

44.32 ± 0.01

45.87 ± 0.02

46.98 ± 0.02

40.92 ± 0.02

Test

Edema rate

0.00 ± 0.01

32.28 ± 0.02

39.56 ± 0.02

36.81 ± 0.02

36.13 ± 0.02

35.41 ± 0.02

25.28 ± 0.02

 

Inhibition rate(%)

 

5.61

7.81

17.32

20.83

24.89

45.26

Standard

Edema rate

0.00 ± 0.01

31.72 ± 0.02

34.11 ± 0.02

31.87 ± 0.02

26.13 ± 0.02

21.09 ± 0.02

17.42 ± 0.02